- Grant Amount – up to €500,000
- Deadline – June 01, 2025
- CLICK HERE TO APPLY
As part of the PharmaVax Ghana programme, the National Vaccine Institute of Ghana and the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH has launched a €500,000 call for proposals to support collaborative partnerships in R&D that promote the discovery, development and production of vaccines, medicines and other pharmaceutical products.
.
The PharmaVax Ghana programme is part of the Team Europe Initiative on Manufacturing and Access to Vaccines, Medicines and Health Technologies in Africa (MAV+) and is co-financed by the European Union (EU) and the German Federal Ministry for Economic Cooperation and Development (BMZ).
.
Objectives
- Identify impactful and innovative vaccine and pharmaceutical R&D projects that are relevant to public health in Ghana and Africa.
- Support concrete R&D projects jointly led and carried out by Ghanaian research institutions and pharmaceutical manufacturers, thereby fostering partnerships and local innovation.
- Contribute to innovation in discovery and product development in Ghana as well as sustainable commercialisation of locally manufactured vaccines and other pharmaceutical products.
- Support Ghanaian stakeholders in strengthening their R&D capacity, sharing results of the R&D projects and build their capacities to apply for further large-scale R&D grants.
Funding Information
- Three funding windows are available for projects spanning a maximum period of 24 months: up to EUR 125,000; up to EUR 300,000; up to EUR 500,000.
- Project duration and end Up to 24 months (up to November 2027)
Eligible Projects
- The screening, identification, as well as efficacy and safety testing for (innovative) chemical and biological molecules in the context of (clinical) development of drugs including herbals, vaccines and sera.
- Innovations in product formulation (e.g. formulations, prolonged release formulations, biosimilars, generics) medical diagnostics and devices for drug application, and product development for under-served patient groups.
- (FDA-approved) Clinical trials of drugs including herbals, vaccines and sera and medical diagnostics and devices for drug application.
Eligibility:
- The technical scope of the proposed R&D project must fall within the requirements.
- The public benefit of the proposed project must be clearly stated and explained in the proposal.
- The lead applicant must be a Ghanaian research institution, i.e. a locally registered public or private entity that has research as a primary organisational objective (e.g. public or private academic departments or research institutes, private R&D companies).
- The proposal must involve at least one FDA-approved, private or public Ghanaian pharmaceutical manufacturer as a co-applicant. The involvement must be proven through a letter of engagement by the manufacturer. This is to be attached to the proposal. The proposal should clearly describe the intended involvement, the contributions (financial, in-kind) and the interest of the manufacturer.
…………………………………………………………………………………………………
At Funding Square, we help African entrepreneurs and organizations access funding through three expert services:
.
- Grant Research Service – Get 50 tailored grant opportunities handpicked for your business or nonprofit, saving you time and effort.
- Grant Proposal Writing – We craft compelling, funder-friendly proposals that grab attention and increase your chances of success.
- Fundraising Business Plan – A powerful, funding-ready business plan designed to attract grants, loans, and investors.
Let’s turn your funding goals into reality!
.
Contact us today by sending us an email at hello@fundingsquare.org